Bath & Body Works (NYSE:BBWI) Trading Down 5.5% – Should You Sell?

featured-image

Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) shares traded down 5.5% during trading on Friday . The stock traded as low as $26.16 and last traded at $26.09. 764,789 shares were traded during mid-day trading, a decline of 83% from the average session volume of 4,633,526 shares. The stock had previously closed [...]

Bath & Body Works, Inc. ( NYSE:BBWI – Get Free Report ) shares traded down 5.5% during trading on Friday .

The stock traded as low as $26.16 and last traded at $26.09.



764,789 shares were traded during mid-day trading, a decline of 83% from the average session volume of 4,633,526 shares. The stock had previously closed at $27.62.

Analysts Set New Price Targets BBWI has been the topic of a number of research analyst reports. Argus restated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $42.

00 to $48.00 in a research note on Friday, January 10th. Raymond James reiterated an “outperform” rating and set a $46.

00 price target (up previously from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. Cowen reissued a “buy” rating on shares of Bath & Body Works in a report on Thursday, February 27th.

Finally, Telsey Advisory Group reaffirmed an “outperform” rating and issued a $43.00 target price on shares of Bath & Body Works in a research note on Thursday, February 27th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock.

According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $44.06.

Check Out Our Latest Stock Analysis on Bath & Body Works Bath & Body Works Price Performance Bath & Body Works ( NYSE:BBWI – Get Free Report ) last announced its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.

04 by $0.05. The business had revenue of $2.

79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.

43% and a negative return on equity of 44.03%. On average, sell-side analysts expect that Bath & Body Works, Inc.

will post 3.3 earnings per share for the current fiscal year. Bath & Body Works Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th.

Investors of record on Friday, February 21st were paid a dividend of $0.20 per share. This represents a $0.

80 annualized dividend and a yield of 3.01%. The ex-dividend date was Friday, February 21st.

Bath & Body Works’s payout ratio is presently 21.98%. Bath & Body Works declared that its board has initiated a share repurchase plan on Thursday, February 27th that allows the company to repurchase $500.

00 million in shares. This repurchase authorization allows the company to purchase up to 6.4% of its shares through open market purchases.

Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued. Institutional Investors Weigh In On Bath & Body Works Several large investors have recently modified their holdings of BBWI. Fifth Third Wealth Advisors LLC grew its position in shares of Bath & Body Works by 4.

9% in the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after purchasing an additional 324 shares during the period. SRS Capital Advisors Inc.

lifted its stake in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc.

now owns 659 shares of the company’s stock valued at $26,000 after buying an additional 329 shares in the last quarter. TD Private Client Wealth LLC boosted its holdings in shares of Bath & Body Works by 24.2% in the third quarter.

TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares during the period. UMB Bank n.a.

increased its position in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.

a. now owns 905 shares of the company’s stock worth $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Northwest Bank & Trust Co raised its holdings in shares of Bath & Body Works by 2.

9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company’s stock worth $533,000 after acquiring an additional 419 shares during the period. 95.

14% of the stock is currently owned by institutional investors. Bath & Body Works Company Profile ( Get Free Report ) Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. See Also Five stocks we like better than Bath & Body Works How to Invest in Small Cap Stocks Robinhood Strategies Could Be a Game-Changer for Young Investors How to Know Which Cryptocurrency to Buy: A Guide for Investors Are These 3 Retail Stocks Oversold or Really in Trouble? 5 Top Rated Dividend Stocks to Consider IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.

com's FREE daily email newsletter ..